Children with multiple nut allergies experienced significant increases in the amounts of allergens they could tolerate with oral immunotherapy using very low doses, according to data published in ...

Treatment with PALYNZIQ led to statistically significant blood phenylalanine (Phe) lowering compared to diet alone in pivotal ...

Treatment with PALYNZIQ led to statistically significant blood phenylalanine (Phe) lowering compared to diet alone in pivotal Phase 3 PEGASUS study PALYNZIQ is the ...

This study uses a Bayesian framework to characterize latent brain state dynamics associated with memory encoding and performance in children, as measured with functional magnetic resonance imaging.

Q4 2025 Earnings Call February 26, 2026 8:30 AM ESTCompany ParticipantsKate Rausch - Head of Investor RelationsPaul Bolno ...

Sarepta Therapeutics, Inc. ( SRPT) Q4 2025 Earnings Call February 25, 2026 4:30 PM EST ...

Blueprint Medicines, a Sanofi company, today announced AYVAKIT® (avapritinib) data showing clinically meaningful outcomes and a well-tolerated long-term safety profile in patients with indolent ...

Trauma and Extremities partnership aligns disciplined approach to portfolio optimization and focuses on delivering long-term value for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global ...

Android 16's accessibility tools can reduce eye strain and headaches by adjusting color temperature and contrast ...

The average smartphone user has around 80 apps installed on their device at a given time. That's a lot of potentially wasted space that could go to even more high-quality videos and images of ...

After our formal remarks, we will open the call for Q&A. I would like to note that during this call, we will be making a number of forward-looking statements. Please refer to Slide 2 on the webcast, ...

The Motley Fool reports that 58% of individual investors plan to buy more stocks in 2026, driven by AI optimism, despite ...